Edition:
United States

Radius Health Inc (RDUS.OQ)

RDUS.OQ on NASDAQ Stock Exchange Global Market

19.48USD
4:00pm EDT
Change (% chg)

$-0.38 (-1.91%)
Prev Close
$19.86
Open
$19.87
Day's High
$19.91
Day's Low
$19.18
Volume
212,138
Avg. Vol
264,487
52-wk High
$41.14
52-wk Low
$16.71

Chart for

About

Radius Health, Inc. is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The Company's lead investigational product candidate, TYMLOS (abaloparatide-SC) injection is developed for the treatment of postmenopausal women with osteoporosi... (more)

Overall

Beta: 0.91
Market Cap(Mil.): $856.78
Shares Outstanding(Mil.): 45.48
Dividend: --
Yield (%): --

Financials

  RDUS.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -5.79 -- --
ROI: -100.26 1.96 12.83
ROE: -150.72 1.12 14.95

BRIEF-Radius Health Reports Q1 Loss Per Share Of $1.37

* RADIUS HEALTH REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE

May 10 2018

Earnings vs. Estimates